BIOMAT Database Logo BIOMAT Database Logo

Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia. 1974

T A Waldmann, and M Durm, and S Broder, and M Blackman, and R M Blaese, and W Strober

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008934 Mitogens Substances that stimulate mitosis and lymphocyte transformation. They include not only substances associated with LECTINS, but also substances from streptococci (associated with streptolysin S) and from strains of alpha-toxin-producing staphylococci. (Stedman, 25th ed) Mitogen,Phytomitogen,Phytomitogens
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T A Waldmann, and M Durm, and S Broder, and M Blackman, and R M Blaese, and W Strober
Defective DNA synthesis by T cells in acquired 'common-variable' hypogammaglobulinaemia on stimulation with mitogens.
April 1989, Clinical and experimental immunology,
T A Waldmann, and M Durm, and S Broder, and M Blackman, and R M Blaese, and W Strober
Role of interleukin-2 and interleukin-6 in the mitogen responsiveness of T cells from patients with 'common-variable' hypogammaglobulinaemia.
September 1990, Clinical and experimental immunology,
T A Waldmann, and M Durm, and S Broder, and M Blackman, and R M Blaese, and W Strober
Acquired common variable hypogammaglobulinaemia and lymphoedema.
January 1988, Postgraduate medical journal,
T A Waldmann, and M Durm, and S Broder, and M Blackman, and R M Blaese, and W Strober
Common variable hypogammaglobulinaemia associated with thymoma.
June 1994, Presse medicale (Paris, France : 1983),
T A Waldmann, and M Durm, and S Broder, and M Blackman, and R M Blaese, and W Strober
[A case of common variable immunodeficiency--hyperactivity of suppressor T cells].
May 1984, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
T A Waldmann, and M Durm, and S Broder, and M Blackman, and R M Blaese, and W Strober
Thymoma and hypogammaglobulinaemia with and without T suppressor cells.
December 1984, Clinical and experimental immunology,
T A Waldmann, and M Durm, and S Broder, and M Blackman, and R M Blaese, and W Strober
Splenic suppressor cells in hypogammaglobulinaemia.
March 1977, British medical journal,
T A Waldmann, and M Durm, and S Broder, and M Blackman, and R M Blaese, and W Strober
B cells in patients with X-linked and 'common variable' hypogammaglobulinaemia.
July 1986, Clinical and experimental immunology,
T A Waldmann, and M Durm, and S Broder, and M Blackman, and R M Blaese, and W Strober
Genetic defects and the role of helper T-cells in the pathogenesis of common variable immunodeficiency.
January 2014, Advanced biomedical research,
T A Waldmann, and M Durm, and S Broder, and M Blackman, and R M Blaese, and W Strober
Letter: Lymphocytes in common variable (adult "acquired") hypogammaglobulinaemia.
October 1974, Lancet (London, England),
Copied contents to your clipboard!